Related Experiment Video
Updated: Feb 1, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
A Full MALDI-Based Approach to Detect Plasmid-Encoded KPC-Producing Klebsiella pneumoniae
Miriam Cordovana1, Markus Kostrzewa2, Jörg Glandorf2
1Laboratory of Bacteriology, Operative Unit of Microbiology, University Hospital of Bologna Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Abstract:
KPC-producing Klebsiella pneumoniae represents a severe public health concern worldwide. The rapid detection of these isolates is of fundamental importance for the adoption of proper antibiotic treatment and infection control measures, and new applications of MALDI-TOF MS technology fit this purpose. In this study, we present a full MALDI-based approach to detect plasmid-encoded KPC-producing strains, accomplished by the automated detection of a KPC-specific peak (at 11,109 m/z) by a specific algorithm integrated into the MALDI Biotyper system (Bruker Daltonik), and the confirmation of carbapenemase activity by STAR-Carba imipenem hydrolysis assay. A total of 6209 K. pneumoniae isolates from Italy and Germany were investigated for the presence of the KPC-related peak, and a subset of them (n = 243) underwent confirmation of carbapenemase activity by STAR-Carba assay. The novel approach was further applied directly to positive blood culture bottles (n = 204), using the bacterial pellet obtained with Sepsityper kit (Bruker Daltonik). The novel approach enabled a reliable and very fast detection of KPC-producing K. pneumoniae strains, from colonies as well as directly from positive blood cultures. The automated peak detection enabled the instant detection of KPC-producing K. pneumoniae during the routine identification process, with excellent specificity (100%) and a good sensitivity (85.1%). The sensitivity is likely mainly related to the prevalence of the specific plasmid harboring clones among all the KPC-producing circulating strains. STAR-Carba carbapenemase confirmation showed 100% sensitivity and specificity, both from colonies and from positive blood cultures.
Insights
Rapidly detect KPC-producing Klebsiella pneumoniae using MALDI-TOF MS. This method accurately identifies carbapenemase-producing Enterobacteriaceae (KPC) from colonies and blood cultures, aiding infection control.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Mass Spectrometry
Background:
- Carbapenemase-producing Klebsiella pneumoniae (KPC) poses a global health threat.
- Timely detection is crucial for effective antibiotic treatment and infection control.
- Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) offers potential for rapid diagnostics.
Purpose of the Study:
- To develop and validate a comprehensive MALDI-TOF MS-based approach for detecting KPC-producing K. pneumoniae.
- To assess the performance of automated KPC-specific peak detection and carbapenemase activity confirmation.
Main Methods:
- A MALDI-TOF MS method was developed to detect a KPC-specific peak (11,109 m/z) using an integrated algorithm.
- Carbapenemase activity was confirmed using the STAR-Carba imipenem hydrolysis assay.
- The approach was tested on 6209 K. pneumoniae isolates and 204 positive blood cultures, with isolates processed using the Sepsityper kit.
Main Results:
- The automated MALDI-TOF MS approach achieved 100% specificity and 85.1% sensitivity for KPC detection from colonies.
- Direct application to positive blood cultures yielded reliable and rapid results.
- STAR-Carba assay demonstrated 100% sensitivity and specificity for carbapenemase confirmation.
Conclusions:
- The developed MALDI-TOF MS approach provides a reliable and rapid method for detecting KPC-producing K. pneumoniae.
- Automated peak detection integrates seamlessly into routine identification workflows.
- This method facilitates prompt implementation of appropriate patient management and infection control strategies.
Related Concept Videos
Encoding
Automatic processing involves the encoding of details like time, space, frequency, and the meaning of words, usually done without conscious...
Plasmids
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
MALDI-TOF Mass Spectrometry

